Incorporating AI into Commercialization Plans
Steve Silvestro explains the value of artificial intelligence in launch plans, benefits to integrating DTC and HCP marketing strategies, and more.
In this exclusive PC Podcast interview, Steve Silvestro, president of OptimizeRx, a digital communications platform, details:
- The benefits to integrating direct-to-consumer (DTC) and healthcare provider (HCP) marketing strategies with technology, especially for patients and providers
- The application of artificial intelligence (AI) toward the pharma marketing stage of commercialization
- Ways that pharma marketers can navigate the rapidly changing landscape of state-level consumer privacy legislation
- Recommendations for pharma brands as they start to think about 2025 planning
The latest episode of The Pharmaceutical Commerce Podcast is available directly on Audioboom, Spotify, or iHeart.
Recent Videos
Related Content
Newron, Myung In Pharm Form Partnership Centered Around Treating Schizophrenia in South Korea
January 14th 2025Article
The license agreement will feature an upcoming Phase III trial and—depending on results—the development, manufacturing, and commercialization of evenamide as a potential treatment option.
